Seikagaku Corp 4548.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
1,008.00quote price arrow down-10.00 (-0.98%)
Volume
67,700
52 week range
951.00 - 1,245.00

...

Loading . . .
  • Open1,013.00
  • Day High1,015.00
  • Day Low1,003.00
  • Prev Close1,018.00
  • 52 Week High1,245.00
  • 52 Week High Date08/27/20
  • 52 Week Low951.00
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap533.11M
  • Shares Out56.43M
  • 10 Day Average Volume53,300
  • Dividend20.00
  • Dividend Yield1.98%
  • Beta
  • YTD % Change-0.88

KEY STATS

  • Open1,013.00
  • Day High1,015.00
  • Day Low1,003.00
  • Prev Close1,018.00
  • 52 Week High1,245.00
  • 52 Week High Date08/27/20
  • 52 Week Low951.00
  • 52 Week Low Date10/30/20
  • Market Cap533.11M
  • Shares Out56.43M
  • 10 Day Average Volume53,300
  • Dividend20.00
  • Dividend Yield1.98%
  • Beta
  • YTD % Change-0.88

RATIOS/PROFITABILITY

  • EPS (TTM)30.10
  • P/E (TTM)33.49
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2020
  • Div Amount10.00
  • Split Date-
  • Split Factor-

Latest From Seikagaku Corp

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business...
Ken Mizutani
President
Address
10F, Marunouchi Center Bldg
1-6-1, Marunouchi
Chiyoda-ku, TKY
100-0005
Japan